Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Addressing the Treatment Deficiency for Osteoporosis Before Hip Fractures: A Prospective Observational Analysis of Pharmacological Risk Factors

  • By

  • Lukas Böck

  • Katharina Kerschan-Schindl

  • Martin Frossard

  • Stefan Hajdu

  • Richard Crevenna

  • Martina Anditsch

  • Gunar Stemer

  • Anna Antoni

  • July 3, 2026

Share

Original Source(s)

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study

  • by Lukas Böck, Katharina Kerschan-Schindl, Martin Frossard, Stefan Hajdu, Richard Crevenna, Martina Anditsch, Gunar Stemer, Anna Antoni

  • July 3, 2026

Related Content

Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

  • July 16, 2026

Osteoimmuno-brain axis: a bridge connecting osteoporosis and cognitive decline and its clinical significance in dementia and Alzheimer’s disease

Research progress on the intervention of osteoporosis by Chinese herbal monomers based on the Nrf2/NF-κB/MAPK pathway